Obesity Clinical Trial
— Lekkere trekOfficial title:
Profiling the Endocannabinoid Response to Hedonic Eating
Verified date | May 2017 |
Source | Wageningen University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Study into the endocannabinoid response to consuming a palatable versus a neutral food.
Status | Completed |
Enrollment | 25 |
Est. completion date | October 8, 2015 |
Est. primary completion date | October 8, 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: - Healthy (self-report) - Dutch - Evaluating one of the used foods as palatable - Evaluating one of the used foods as neutral - Hb value between 8.1 and 11.0 mmol/L at screening Exclusion Criteria: - restraint eating - lack of appetite - difficulties eating/swallowing - endocrine disorders - energy restricted diet two months prior to study - weight change > 5 kg in two months prior to study - stomach or bowel disease - taste or smell disorders (self-report) - not consuming foods used in the study - smoking > 1 cigarette per day - drinking > 21 units alcohol per week |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Wageningen University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Endocannainoid levels | To assess changes in endocannabinoid plasma levels prior to, during and after eating a palatable versus a neutral food | prior to, during and two hours after eating | |
Secondary | Pancreatic polypeptide (pg/ml) | To assess changes in pancreatic polypeptide plasma levels prior to, during and after eating a palatable versus a neutral food | prior to, during and two hours after eating | |
Secondary | Ghrelin (pg/ml) | To assess changes in ghrelin plasma levels prior to, during and after eating a palatable versus a neutral food | prior to, during and two hours after eating |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |